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Kaposi’s sarcoma-associated herpesvirus (KSHV) ex-
presses numerous intronless mRNAs that are unable to
access splicing-dependent cellular mRNA nuclear export
pathways. To circumvent this problem, KSHV encodes the
open reading frame 57 (ORF57) protein, which orches-
trates the formation of an export-competent virus ribonu-
cleoprotein particle comprising the nuclear export
complex hTREX, but not the exon-junction complex (EJC).
Interestingly, EJCs stimulate mRNA translation, which
raises the intriguing question of how intronless KSHV
transcripts are efﬁciently translated. Herein, we show that
ORF57 associates with components of the 48S pre-initiation
complex and co-sediments with the 40S ribosomal subunits.
Strikingly, we observed a direct interaction between ORF57
and PYM, a cellular protein that enhances translation by
recruiting the 48S pre-initiation complex to newly exported
mRNAs, through an interaction with the EJC. Moreover,
detailed biochemical analysis suggests that ORF57 recruits
PYM to intronless KSHV mRNA and PYM then facilitates the
association of ORF57 and the cellular translation machinery.
We, therefore, propose a model whereby ORF57 interacts
directly with PYM to enhance translation of intronless
KSHV transcripts.
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Introduction
The cellular machineries involved in processing a nascent
mRNA are both numerous and complex (Kohler and Hurt,
2007). Of these, the spliceosome is the largest and perhaps
the most intricate, functioning to remove non-coding intronic
sequence from multi-exon genes, which constitute the
majority of genes expressed in higher eukaryotes (Jurica and
Moore, 2003). Intriguingly, the act of splicing is itself coupled
to the deposition of two distinct multi-protein complexes on a
burgeoning mRNA, namely the hTREX complex and the exon-
junction complex (EJC) (Reed and Cheng, 2005). The hTREX
complex is deposited at the 50 end of the ﬁrst exon, where it
facilitates the polarized nuclear export of the spliced mRNA
(Cheng et al, 2006). In contrast, the EJC is deposited 20–24
nucleotides upstream of each exon–exon boundary on a
spliced mRNA (Le Hir et al, 2000) and has key functional
roles in mRNA surveillance (Chang et al, 2007) and transla-
tional enhancement (Nott et al, 2004; Gudikote et al, 2005).
The observation that a spliced mRNA exhibits enhanced
translation was initially made over two decades ago (Callis
et al, 1987) and has subsequently been supported by numer-
ous studies (Braddock et al, 1994; Matsumoto et al, 1998;
Lu and Cullen, 2003). Furthermore, it is clear that deposition
of the EJC is both necessary and sufﬁcient for the observed
splicing-dependent increase in translation (Nott et al, 2004).
Several mechanisms have been proposed providing insight
into how the EJC may inﬂuence translational efﬁciency. One
example is through the adapter protein, SKAR, recently
reported to associate with the EJC and recruit the mTOR-
target kinase, S6K1 (Ma et al, 2008). S6K1 has been shown to
associate with and phosphorylate components of the pre-
initiation complex, leading to an increase in translation
(Peterson and Sabatini, 2005). A second study investigating
the EJC-associated protein, PYM, provides a mutually exclu-
sive mechanism for EJC-mediated translational enhance-
ment. PYM functions to recruit the 40S ribosomal subunit
to spliced mRNAs through a cytoplasmic interaction with the
EJC components Y14 and Magoh (Bono et al, 2004; Diem
et al, 2007). In each case, siRNA-mediated depletion of SKAR
or PYM leads to a signiﬁcant decrease in the translation of
a spliced reporter mRNA (Diem et al, 2007; Ma et al, 2008).
Kaposi’s sarcoma-associated herpesvirus (KSHV) is a g-2
herpesvirus associated with a number of AIDS-related malig-
nancies (Chang and Moore, 1996). In contrast to higher
eukaryotes, all herpesviruses express numerous lytic intron-
less mRNAs. As herpesviruses rely on host-cell machinery for
mRNA export and translation, a caveat exists concerning the
mechanisms by which these viral intronless mRNAs are
exported from the nucleus and efﬁciently translated in the
cytoplasm, given that splicing is an essential pre-requisite
of both these events. In KSHV, the nuclear export of
intronless viral mRNA is facilitated by the virus-encoded,
intron-containing, open reading frame 57 (ORF57) protein
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1851(Swaminathan, 2005). KSHV ORF57 interacts directly with
the export adapter, Aly, and shuttles between the nucleus and
the cytoplasm promoting the nuclear export of intronless
viral mRNAs through a TAP-mediated pathway (Malik et al,
2004). These properties are also conserved in ORF57 homo-
logues throughout herpesviruses such as ICP27 from Herpes
simplex virus type-1 (HSV-1), SM protein from Epstein–Barr
virus (EBV) (Koffa et al, 2001; Ruvolo et al, 2001; Chen et al,
2005; Sergeant et al, 2008) and Herpesvirus saimiri (HVS)
ORF57 protein (Goodwin and Whitehouse, 2001; Williams
et al, 2005; Boyne et al, 2008a; Colgan et al, 2009).
We recently investigated the composition of an export-
competent intronless KSHV ribonucleoprotein particle
(vRNP) and showed that ORF57 functions to recruit the
hTREX complex to intronless viral mRNA, an event that is
essential for viral intronless mRNA export and KSHV replica-
tion (Boyne et al, 2008a). In contrast, ORF57 failed to recruit
an EJC to intronless KSHV mRNA. Given the function of the
EJC in translation enhancement, its absence from intronless
viral mRNA is intriguing and we hypothesized that the lack of
an EJC may negatively impact on the translational efﬁciency
of these intronless viral mRNAs. Therefore, we set out to test
whether, in the absence of an EJC, the ORF57 protein was
able to enhance translation of intronless KSHV mRNAs.
We show that ORF57 is able to enhance the translation of
an intronless KSHV mRNA in vitro. Sucrose gradient analysis
revealed that ORF57 sediments predominantly with the 40S
ribosomal subunit and interacts with the components of the
translation machinery. Intriguingly, we report a novel inter-
action between ORF57 and the recently identiﬁed translation
enhancement factor, PYM. Biochemical analysis revealed that
PYM only binds to intronless KSHV mRNA in the presence
of ORF57 and that siRNA-mediated depletion of PYM resulted
in a marked reduction in the association of ORF57 with compo-
nents of the translational machinery. To determine whether
PYM is essential for the observed enhancement of intronless
KSHV mRNA translation, functional assays were carried out
in PYM depleted or cells expressing an ORF57-speciﬁc domi-
nant negative mutant form of PYM. In both cases, a decrease
in functional PYM resulted in a speciﬁc decrease in the
efﬁciency of intronless KSHV mRNA translation. Together,
these data suggest that ORF57 functions to enhance the
translation of intronless KSHV mRNAs by recruiting the
translational enhancement protein, PYM and promoting the
recruitment of the pre-initiation complex to intronless KSHV
mRNA. Importantly, this work provides the ﬁrst mechanistic
model for how KSHVensures the efﬁcient translation of viral
intronless mRNAs.
Results
ORF57 enhances the translation of an intronless
KSHV mRNA
To determine whether ORF57 is capable of enhancing the
translation of an intronless KSHV mRNA, an in vitro transla-
tion assay was used. The KSHV ORF39 (gM) gene was in vitro
transcribed from a plasmid template and equal amounts of
RNA used in radio-labelled in vitro translation reactions.
A rate-limiting amount of gM mRNA (2.5ng) template was
purposefully added to each translation assay to ensure that
any enhancement effect was detectable. Each assay was then
spiked with increasing amounts of either a negative control
(bunyamwera virus nucleocapsid protein; Rodgers et al,
2006), a known translational enhancer (glutathione S-trans-
ferase (GST)-PYM; Diem et al, 2007), a deletion mutant of
PYM unable to enhance translation (GSTPYMDC), or GST-
ORF57 protein (Supplementary Figure S1). Results show that
the level of gM translation observed in samples spiked with
the negative controls, bunyamwera virus nucleocapsid pro-
tein or GSTPYMDC remained consistent, showing no increase
in translation. In contrast, samples spiked with PYM dis-
played a dose-dependent increase in translation of gM (up to
eight-fold) in relation to the amount of GST-PYM added
(Figure 1Ai). Strikingly, addition of GST-ORF57 led to a
similar dose-dependent increase in the translation of gM
mRNA (Figure 1Ai).
To determine the speciﬁcity of ORF57’s translation en-
hancement, the in vitro translation assay was repeated
using a rate-limiting amount of a control mRNA. Results
show that PYM displayed a dose-dependent translation en-
hancement of luciferase; however, in contrast, no increase in
translation was observed in samples spiked with increasing
amounts of ORF57 protein (Figure 1Aii). This suggests that
ORF57-mediated translation enhancement is not merely a
non-speciﬁc enhancement due to increasing RNA stability
but is speciﬁc to viral intronless mRNAs. Moreover, to ensure
that ORF57 enhances cap-dependent translation, rate-limiting
amounts of control luciferase and gM mRNAs were in vitro
translated using human cell line extracts. Results show that
ORF57 displays a dose-dependent translation increase of gM;
however, no increase was observed with the control lucifer-
ase (Figure 1Aiii). Therefore, these data suggest that ORF57 is
able to enhance the translation of the intronless gM mRNA.
ORF57 sediments with the 40S ribosomal subunit
Given that ORF57 is able to enhance the translation of a
KSHV intronless mRNA in vitro, we next sought to determine
whether ORF57 associates with ribosomal subunits during
lytic replication. BCBL-1 cells are latently infected with KSHV,
and treatment of these cells with the phorbel ester, TPA,
triggers lytic reactivation. To determine whether ORF57 as-
sociates with the components of the cellular translation
machinery, BCBL-1 cells were treated with TPA for 16h to
induce KSHV lytic replication and then cyclohexamide was
added for 2h to stabilize polysomes. Cytoplasmic cell lysate
was isolated from the reactivated BCBL-1 cells and separated
across a 5–20% linear sucrose gradient, to determine the
sedimentation proﬁle of ORF57 in relation to the large and
small ribosomal subunits. Sedimentation was performed in
the presence of 20mM EDTA, which elicits the dissociation of
ribosomes into the large (60S) and small (40S) subunits.
Following centrifugation, fractions were collected and ana-
lysed for ORF57 protein and RNA content. The presence of
28S and 18S rRNA served as a marker for the large and small
ribosomal subunits respectively, as described earlier (Diem
et al, 2007). The majority of ORF57 fractionated with the
18S rRNA, indicating that a signiﬁcant fraction of ORF57
co-sediments with the 40S ribosomal subunit (Figure 1B),
suggesting that ORF57 may be associated with the pre-initia-
tion complex, although we cannot conclusively determine
whether ORF57 sediments with 40S subunits or binds RNA
associated with 40S subunits. However, to conﬁrm that
components of the pre-initiation complex were also present
in the 18S rRNA-rich fractions, western blot analysis was also
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Figure 1 ORF57 enhances translation of an intronless viral mRNA. (Ai) Intronless KSHV gM RNAwas transcribed in vitro and equal amounts
carried over into
35S-methionine-labelled in vitro rabbit reticulocyte translation reactions, spiked with increasing amounts (0.5, 1 or 2.5mg) of
either puriﬁed bunyamwera virus nucleocapsid protein, GST-PYM, GST-ORF57 or GST-PYMDC. (Aii) Luciferase RNA was transcribed in vitro
and equal amounts carried over into
35S-methionine-labelled in vitro rabbit reticulocyte translation reactions, spiked with increasing amounts
(0, 1 or 2.5mg) of GST-PYM or GST-ORF57. (Aiii) gM or luciferase RNAwas transcribed in vitro and equal amounts were carried over into
35S-
methionine-labelled in vitro human cell extract translation reactions, spiked with increasing amounts (0, 1 or 2.5mg) of GST-ORF57. Translation
reactions were separated by SDS–PAGE and proteins detected by autoradiography and quantiﬁed by densitometry. (B) Cytoplasmic lysate from
reactivated BCBL-1 cells treated with cyclohexamide was separated by sucrose gradient fractionation in the presence of 20mM EDTA. Fractions
were analysed for rRNA and protein content by agarose gel electrophoresis or western blot analysis, respectively.
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and eIF4A. As shown in Figure 1B, PYM and eIF4A, like
ORF57, are present predominantly in the 18S-rich fractions,
conﬁrming that these fractions contain components of the
cellular translation machinery.
ORF57 interacts with the components of the translation
machinery
Having established that ORF57 enhances the translation of a
KSHV intronless mRNA and co-sediments with the 40S
ribosomal subunit, we next sought to determine whether
ORF57 interacts with components of the translation machin-
ery. BCBL-1 cells were treated with TPA for 16h to activate
lytic gene expression, and co-immunoprecipitations (Co-IPs)
were performed using a panel of antibodies speciﬁc for the
translation factors eIF4A-, eIF4E-, eIF4G- and PABP, in addi-
tion to a negative control antibody (a-SC35). ORF57 was
readily co-precipitated by each of the translation factor-spe-
ciﬁc antibodies in contrast to negative controls (Figure 2A).
As a further control, we assessed whether these translation
factors precipitated another KSHV lytic protein, the viral
transcription factor RTA. No interaction was observed with
RTA (Figure 2A), suggesting that the interaction between
ORF57 and these translation factors was not due to a non-
speciﬁc interaction. Moreover, the observed interaction
between ORF57 and the above translation factors was still
detected when Co-IPs were performed in the presence of
RNase, suggesting that these interactions may not be a result
of RNA bridging (Supplementary Figure S2A). To ensure
appropriate RNase activity, a control Co-IP experiment was
performed assessing the interaction between two RNA-bind-
ing proteins, previously shown to be RNA dependent, namely
Aly and UIF (Hautbergue et al, 2009). Supplementary Figure
S3 shows that the RNase treatment was efﬁcient, as in the
presence of RNase, the interaction between Aly and UIF was
abolished. However, although this analysis suggests that the
interactions between ORF57 and translation factors are RNA
independent, this analysis only shows that the interactions
are RNase resistant. Therefore, the Co-IP experiments were
repeated in transfected 293T cells using an ORF57 mutant,
ORF57DRGG2, which has been shown earlier to be unable to
bind RNA (Nekorchuk et al, 2007) and Supplementary Figure
S2B. Results show that this ORF57 RNA-binding mutant can
still interact with translation factors (Figure 2A), suggesting
an RNA-independent interaction.
ORF57 interacts with PYM
Given recent data showing that EJCs are coupled to the
translational machinery through PYM (Diem et al, 2007),
we hypothesized that ORF57 may link intronless KSHV
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Figure 2 ORF57 associates with components of the 48S pre-initiation complex and the EJC adapter protein, PYM. (A) Immunoprecipitations
using eIF4A-, eIF4E-, eIF4G- or PABP-speciﬁc antibodies were performed on reactivated BCBL-1 cell or ORF57DRGG2-transfected cell lysates, in
addition to no antibody and negative control antibody (a-SC35) controls. Precipitated ORF57 or RTA protein was detected by western blot
analysis using ORF57- or RTA-speciﬁc antibodies, total reactivated or transfected cell lysate served as a positive control (input¼10%).
(B) Immunoprecipitations were performed on reactivated BCBL-1 or ORF57DRGG2-transfected cell lysates using either an ORF57- or
PYM-speciﬁc antibody, in addition to no antibody and negative control antibody (a-SC35) controls. Western blot analysis was performed
using either a PYM- or ORF57-speciﬁc antibody, total reactivated or transfected cell lysate served as a positive control (input¼10%). Loading
controls for each co-immunoprecipitation are also shown. (C) Recombinant GST-, GST-Hpr1-, GST-Aly- and GST-PYM-bound glutathione-
agarose beads (indicated by the solid triangles) were incubated with puriﬁed baculovirus-expressed recombinant ORF57-6xHis or HIV-Nef-
6xHis. After washes, bound proteins were analysed by western blot using a His-speciﬁc antibody. Puriﬁed ORF57-6xHis or HIV-Nef-6xHis
protein served as a positive control (input). (D) Cells were transfected with (i) pORF47 or (ii) pORF50 in the absence or presence of pGFP
or pORF57GFP. After UV crosslinking, RNA-IPs were performed using no antibody, negative antibody control (a-p53), PYM-, eIF4A3- and
ORF57-speciﬁc antibodies. Total RNA served as a positive control for the PCR (input).
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PYM. To test this hypothesis, BCBL-1 cells were reactivated
and RNase-treated cell lysates used in Co-IP experiments with
either ORF57- or PYM-speciﬁc antibodies. Moreover, Co-IP
assays were performed in 293T cells transfected with
ORF57DRGG2. We were able to detect an interaction between
ORF57 and PYM in reactivated BCBL-1 cells and in
ORF57DRGG2-transfected cells (Figure 2B). Furthermore, to
establish whether the observed interaction between ORF57
and PYM was direct, GST-pull-down experiments were per-
formed using puriﬁed baculovirus-expressed recombinant
ORF57-6xHis protein and a negative control baculovirus-
expressed protein, HIV-Nef-6xHis (Harris and Coates, 1993).
ORF57-6xHis protein was precipitated by GST-Aly, but failed
to interact with GST-Hpr1 or GSTalone (Figure 2C). Critically,
ORF57-6xHis was also clearly precipitated by GST-PYM,
suggesting that ORF57-6xHis and PYM interact directly
in vitro (Figure 2C). No interaction was observed with the
negative control HIV-Nef-6xHis. Although these experiments
do not completely rule out nucleic acid contamination,
which could lead to RNA bridging, the combined data suggest
that the interaction between ORF57 and PYM is RNA
independent.
ORF57 facilitates the binding of PYM to KSHV intronless
mRNA
To obtain further evidence that PYM has a function in ORF57-
mediated translational enhancement, we next determined
whether PYM is bound to a KSHV intronless mRNA. RNA
immunoprecipitations were performed using PYM-, eIF4A3-
and ORF57-speciﬁc antibodies on 293T cell lysates trans-
fected with an intronless KSHV mRNA reporter vector
(pORF47), in the absence or presence of pORF57GFP. We
were only able to detect PYM bound to the intronless ORF47
mRNA in cells that co-expressed ORF57; in contrast, no
interaction was observed in the absence of ORF57, suggesting
that ORF57 facilitates the binding of PYM to intronless KSHV
ORF47 mRNA (Figure 2Di). Importantly, no recruitment of
the core EJC protein, eIF4A3 was observed either in the
absence or presence of ORF57, demonstrating that ORF57
licenses the recruitment of PYM to intronless mRNAs in the
absence of the core EJC protein, eIF4A3. The recruitment of
ORF57GFP to the intronless ORF47 mRNA served as a
positive control (Boyne et al, 2008b). Moreover, to conﬁrm
that the eIF4A3 antibody could precipitate RNA, experiments
were repeated using 293T cell lysates transfected with
a spliced KSHV mRNA reporter vector (pORF50), in the
absence and presence of ORF57. Here, both PYM and eIF4A3
bound to the spliced mRNA independent of ORF57 (Figure
2Dii). These data, therefore, support the hypothesis that
ORF57 promotes the recruitment of PYM to ORF47 mRNA
and that this recruitment occurs in the absence of an EJC.
ORF57 redistributes PYM and some components
of the pre-initiation complex to the nucleolus
ORF57 is a nucleo-cytoplasmic protein that localizes predo-
minately to the nucleus, speciﬁcally nuclear speckles and
nucleoli (Majerciak et al, 2006; Boyne and Whitehouse,
2009), whereas PYM and components of the translation
machinery are generally located in the cytoplasm (Diem
et al, 2007). Considering ORF57 interacts with PYM and
several translation factors, we were interested to determine
whether ORF57 expression had any effect on the subcellular
localization of PYM and members of the pre-initiation com-
plex. To this end, 293T cells were cultured on poly-L lysine-
coated coverslips and transfected with pORF57GFP either
alone or in combination with PYM-FLAG. Indirect immuno-
ﬂuorescence was performed for PYM-FLAG, PABP and eIF4G
and staining analysed by confocal microscopy. We were
intrigued to discover that expression of ORF57GFP resulted
in the redistribution of a small proportion of PYM and PABP
to the nucleolus (Figure 3Ai and ii). This redistribution was
evident in B60% of cells analysed (n¼300). In contrast, and
in way of an internal control for non-speciﬁc detection of
GFP-ﬂuorescence in the TRITC channel, no relocalization
of eIF4G was observed in the presence of ORF57 (Figure 3Aiii).
To conﬁrm these results in KSHV-infected cells and to ensure
relocalization is not an overexpression artefact, indirect im-
munoﬂuorescence was performed on BCBL-1-reactivated
cells using PYM- and ORF57-speciﬁc antibodies and staining
analysed by confocal microscopy. We observed a clear co-
localization of PYM with ORF57 in the nucleolus in reacti-
vated BCBL-1 cells, which is absent in the unreactivated
control (Figure 3B). Moreover, these experiments were per-
formed with two previously characterized PYM mutants,
termed PYMDN19-54 and PYMDC53 that were no longer
able to interact with the EJC and the 48S pre-initiation
complex, respectively (Diem et al, 2007). Results show that
a small proportion of the deletion mutants are also redis-
tributed to the nucleolus in the presence of ORF57, suggesting
that ORF57 can interact with PYM in the nucleolus in the
absence of the domains required for PYM’s interaction
with translation factors or EJC components (Supplementary
Figure S4).
PYM links ORF57 to the translational machinery
Having established that ORF57 associates with the compo-
nents of the pre-initiation complex and interacts directly with
PYM, we next sought to determine whether PYM functions
as an adapter between ORF57 and pre-initiation complex
factors. To this end, 293T cells were transfected with
pORF57GFP with either mock, scramble or PYM-speciﬁc
siRNAs. An almost complete knockdown of PYM levels was
achieved 48h post-transfection, when compared with b-actin
loading control (Figure 4A). Control or PYM-depleted cell
lysates were then immunoprecipitated using eIF4A-, eIF4G-
or PABP-speciﬁc antibodies in addition to negative (no anti-
body and a-p53) and positive (the hTREX component, hHpr1
speciﬁc) controls. Western blot analysis revealed that in each
case, the amount of ORF57GFP precipitated by components
of the translation machinery (eIF4A, eIF4G and PABP) was
dramatically reduced in PYM-depleted cells. In contrast, the
interaction between ORF57GFP and hHpr1 was not affected
by depletion of PYM, demonstrating that the reduction in
ORF57GFP precipitation in PYM-depleted cells was speciﬁc
for components of the translation machinery (Figure 4B).
Western blot analysis was also performed to compare starting
levels of eIF4A, eIF4G and PABP in mock, scrambled and
PYM-depleted samples, results show that PABP levels are
unaffected by PYM depletion; however, there are observable
decreases in eIF4A and eIF4G, although this does not detract
from the ﬁnding that association with ORF57 and the transla-
tion factors are signiﬁcantly reduced in PYM-depleted cells
(Figure 4C). These data suggest that PYM is required for the
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initiation complex.
PYM is essential for ORF57-mediated translational
enhancement of intronless KSHV mRNA
We next investigated whether PYM was required for the
efﬁcient translation of intronless viral mRNA during KSHV
replication. To this end, siRNA-mediated depletion of PYM
was used in the 293T BAC36 cell system, which harbours the
recombinant KSHV-BAC36 genome (Gao et al, 2003; Wilson
et al, 2007). However, one caveat of this system is that PYM
depletion could inhibit production of the ORF57 protein itself.
Therefore, to prevent inhibition of ORF57 protein production,
cells were concurrently reactivated using TPA and either
DAPI DAPI ORF57GFP Mock
DAPI DAPI ORF57GFP Mock
DAPI DAPI ORF57GFP Mock
PYM-Flag PYM-Flag Merge Merge
PABP PABP Merge Merge
elF4G elF4G Merge Merge
i A
ii
iii
Figure 3 KSHV ORF57 redistributes PYM and some components of the pre-initiation complex to the nucleolus. (Ai) 293T cells were co-
transfected with pORF57GFP and pPYM-FLAG, incubated for 24h, ﬁxed and immunoﬂuorescence staining performed using a FLAG-speciﬁc
antibody. 293T cells were transfected with pORF57GFP, incubated for 24h, ﬁxed and immunoﬂuorescence staining performed using (Aii)a
PABP-speciﬁc antibody and (Aiii) an eIF4G-speciﬁc antibody. (B) BCBL-1 cells were either left untreated or were reactivated by treating with
TPA (20ng/ml) for 16h, ﬁxed and immunoﬂuorescence staining performed using ORF57- and PYM-speciﬁc antibodies.
Interaction of KSHV ORF57 with PYM and viral intronless mRNAs
JR Boyne et al
The EMBO Journal VOL 29 | NO 11 | 2010 &2010 European Molecular Biology Organization 1856mock transfected or transfected with scramble or PYM-spe-
ciﬁc siRNA, which allowed sufﬁcient ORF57 protein to be
produced before optimal PYM depletion. Protein and RNA
samples were then taken at t¼0h (untreated), t¼24h and
t¼48h time points for analysis by semi-quantitative RT–PCR
and western blotting. To conﬁrm the knockdown of PYM,
western blot analysis was performed for each time point
using a PYM-speciﬁc antibody. As shown in Figure 5, we
observed limited knockdown of PYM at 24h post-transfec-
tion; however, by 48h, almost complete knockdown of PYM
was achieved. Subsequently, we assessed whether the deple-
tion of PYM had any effect on the efﬁciency of translation of
DAPI ORF57 DAPI ORF57
PYM Merge PYM Merge
Untreated BCBL-1 cells Reactivated BCBL-1 cells
B
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Figure 4 PYM mediates the association of ORF57 and the pre-initiation complex. (A) 293Tcells were transfected with pORF57GFP in addition
to either mock, scramble siRNA or PYM-speciﬁc siRNA and incubated for 48h. Total protein (100mg) was analysed by western blotting using
PYM- and b-actin-speciﬁc (loading control) antibodies to conﬁrm depletion of PYM. (B) PYM-depleted cell lysates were generated as described
in Figure 4A and immunoprecipitations were performed using either eIF4A-, eIF4G-, PABP- or hHpr1-speciﬁc antibodies, in addition to negative
controls. Western blot analysis was then performed using a GFP-speciﬁc antibody to detect precipitated ORF57. Total transfected cell lysate
served as a positive control for expression of ORF57 (input). Loading controls for each co-immunoprecipitation are also shown. (C) Total
protein was isolated at 48h from PYM-depleted cells and western blot analysis performed to assess eIF4A, eIF4G and PABP levels.
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were chosen due to the availability of suitable antibody
reagents. Western blot analysis revealed that 293T-BAC36
cells depleted for PYM produced signiﬁcantly less ORF54
and ORF59 protein compared with mock or scramble-trans-
fected controls. To ensure that this reduction in protein levels
was due to an effect on translation and not mRNA export or
stability, semi-quantitative RT–PCR was performed on RNA
samples taken from each time point to determine the mRNA
levels for ORF54 and ORF59. We observed no difference in
ORF54 or ORF59 mRNA levels, irrespective of PYM status
(Figure 5). Importantly, protein levels for the spliced ORF57
gene product were comparable between control and siRNA-
transfected samples at each time point, suggesting that the
observed reduction of ORF54 and ORF59 protein was not due
to depletion of ORF57 and as such intronless viral mRNA
export. It should be noted that as predicted, due to the
temporal nature of expression during reactivation, a decrease
in ORF57 expression was seen at 48h, compared with 24h
(Figure 5).
Furthermore, to exclude the possibility that PYM depletion
alters the nuclear–cytoplasmic distribution of viral mRNA,
293T BAC36 cells were transfected with either mock, scram-
ble or PYM-speciﬁc siRNA and concurrently reactivated using
TPA. RNA was then isolated at 48h post-reactivation from
nuclear and cytoplasmic fractions and ORF59 mRNA levels
assessed using qRT–PCR. Results show no signiﬁcant varia-
tion in nuclear–cytoplasmic mRNA levels in mock, scrambled
and PYM-depleted samples (Supplementary Figure S5).
Furthermore, to conﬁrm the speciﬁcity of the PYM-speciﬁc
siRNAs, a second control siRNA was used in similar studies.
293T BAC36 cells were transfected with either mock or a
second control luciferase-speciﬁc siRNA (Grifﬁths and
Whitehouse, 2007) and concurrently reactivated using TPA.
Results show that the second control siRNA does not sig-
niﬁcantly affect mRNA nuclear–cytoplasmic levels or protein
levels (Supplementary Figure S6). Therefore, together these
data suggest that PYM is essential for the efﬁcient translation
of intronless KSHV mRNAs during lytic replication.
However, one caveat of using siRNA-mediated PYM deple-
tion to assess the effect on intronless KSHV mRNA translation
is that PYM depletion is likely to also alter the expression of
some cellular mRNAs. Therefore, it was desirable to develop
an ORF57-speciﬁc functional assay to test the function of
PYM in ORF57-mediated translational enhancement, without
effecting cellular translation. As mentioned earlier, Diem et al
(2007) characterized two PYM mutants, termed PYMDN19-54
and PYMDC53 that were no longer able to interact with the
EJC and the 48S pre-initiation complex, respectively. We
hypothesized that should a PYM mutant lacking the N- and
C-terminus retain an interaction with ORF57, then it will
function in a dominant negative capacity by speciﬁcally
sequestering ORF57 away from wild-type PYM, while not
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Figure 5 Knockdown of PYM impairs intronless KSHV mRNA
translation. 293T BAC36 cells were transfected with either
mock, scramble siRNA or PYM-speciﬁc siRNA and concurrently
reactivated using TPA (20ng/ml). Total protein and RNA was
isolated at the indicated time points and analysed by western
blotting and RT–PCR, respectively, using the indicated antibodies
and oligonucleotides.
Figure 6 An ORF57-speciﬁc dominant negative PYM mutant prevents ORF57 association with the 48S pre-initiation complex and perturbs
ORF57-mediated intronless KSHV mRNA translation. (A) 293T cells were transfected with pORF57GFP in addition to either pFLAG, pPYM-
FLAG, pPYMDN19-54-FLAG, pPYMDC53-FLAG and pPYMDNDC-FLAG, and immunoprecipitations were performed using FLAG-afﬁnity beads.
Western blot analysis was then performed using the indicated antibodies to detect the precipitated proteins. To detect the expression of each
PYM-FLAG protein (indicated by the solid triangles), total cell lysate was analysed by western blotting using an FLAG-speciﬁc antibody. Two
different autoradiograph exposures (exp.) are shown (5 and 20s), as PYMDNDC is fused to a single FLAG epitope (as opposed three for the
other fusion proteins) and therefore generates a weaker signal. Loading controls for each co-immunoprecipitation are also shown. (B) 293T
cells were transfected with either pGFP or pORF57GFP in addition to either pPYM-FLAG or PYMDNDC-FLAG and an immunoprecipitation
performed using a GFP-speciﬁc antibody. Western blot analysis was then performed using the indicated antibodies to detect precipitated
proteins. Loading controls for each co-immunoprecipitation are also shown. (C) 293Tcells were triple transfected with either pORF47GFP or
pgB-HA, in the presence or absence of pCherry or pORF57Cherry and either pPYM-FLAG or pPYMDNDC-FLAG. At 24h post-transfection,
cytoplasmic RNAwas isolated from each sample and 1mg of RNAwas used to generate cDNA using reverse transcriptase. A measure of 10ng of
cDNA was then used in qRT–PCR reactions. Fold increase was determined by DDcTand statistical signiﬁcance by a non-paired t-test. All data
are representative of three independent experiments and presented as fold increase versus pCherry-transfected controls. (D) 293T cells were
triple transfected with either pCherry or pORF57Cherry in addition to either pFLAG, pPYM-FLAG or pPYMDNDC-FLAG and either pORF47GFP
or pgB-HA. At 24h post-transfection, western blot analysis was performed using 25mg of total protein extract and the indicated antibodies to
detect protein expression levels. To detect the expression of PYM-FLAG and PYMDNDC-FLAG, total cell lysate was analysed by western blotting
using a FLAG-speciﬁc antibody. Two different autoradiograph exposures (exp.) are shown (5 and 20s) as PYMDNDC is fused to a single FLAG
epitope (as opposed three for the other fusion proteins) and therefore generates a weaker signal. (E) Densitometry analysis was performed on
three independent transfection experiments described in Figure 6D to determine the relative levels of ORF47GFP and gB-HA protein compared
with controls and the standard error calculated (n¼3). (F) 293T-BAC36 cells were transfected with the indicated vectors and concurrently
reactivated using TPA. After 72h, lytic virus replication was assayed by harvesting the supernatant. The supernatant was used to infect 293T
cells, and 48h later, the level of virus infection was scored by direct immunoﬂuorescence (n¼3).
Interaction of KSHV ORF57 with PYM and viral intronless mRNAs
JR Boyne et al
The EMBO Journal VOL 29 | NO 11 | 2010 &2010 European Molecular Biology Organization 1858affecting cellular translation, due to the removal of the EJCs
and pre-initiation complex-binding domains. To test this
hypothesis, we generated a FLAG-tagged PYM mutant,
PYMDNDC-FLAG, which has 54 amino acids deleted from
the N-terminus and 53 amino acids deleted from the
C-terminus, and assessed the binding of PYMDNDC-FLAG to
ORF57, Magoh (EJC) or eIF4G (pre-initiation complex). 293T
cells were transiently transfected with either pFLAG, pPYM-
FLAG, pPYMDN19-54-FLAG, pPYMDC53-FLAG or pPYMD
NDC-FLAG and Co-IPs performed using FLAG-afﬁnity
beads. As expected, PYM-FLAG precipitated ORF57, Magoh
and eIF4G, whereas PYMDN19-54-FLAG and PYMDC53-FLAG
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and eIF4G. respectively (Figure 6A), in agreement with ear-
lier ﬁndings (Diem et al, 2007). As predicted, PYMDNDC-
FLAG did not precipitate Magoh or eIF4G, in contrast, ORF57
was still readily precipitated (Figure 6A). It should be noted
that ORF57 is sometimes observed as a doublet due to
caspase 7 cleavage (Majerciak et al, 2010). Moreover, the
different amounts of PYM deletion mutants detected using a-
FLAG antibody reﬂects the fact that PYMDNDC is fused to a
single FLAG epitope, whereas PYM, PYMDN19-54 and
PYMDC53 are fused to three FLAG epitopes (Figure 6A,
lower panel, short and long exposure). This interpretation
is supported by the fact that similar amounts of ORF57 are
precipitated by PYMDNDC-FLAG compared with each of the
Figure 6 Continued.
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PYMDNDC-FLAG is an ideal construct to act as an ORF57-
speciﬁc dominant negative mutant for PYM function.
To test whether PYMDNDC-FLAG functions as an ORF57-
speciﬁc dominant negative mutant, we assessed the binding
of ORF57 to the 48S-pre-initiation complex in the absence
or presence of PYMDNDC-FLAG. We have shown earlier
that PYM is required for the association of ORF57 with
components of the 48S pre-initiation complex, therefore, if
PYMDNDC-FLAG functions to titrate ORF57 away from en-
dogenous PYM one would predict that the proportion of
ORF57 associated with the 48S pre-initiation complex com-
ponents, such as eIF4G, would decrease, whereas PYM-
independent interactions, such as hHpr1 (hTREX protein),
would be unaffected. 293T cells were co-transfected with
either pGFP or pORF57GFP and pFLAG or pPYMDNDC-
FLAG, before immunoprecipitation using an ORF57-speciﬁc
antibody. Western blot analysis was then performed using
eIF4G- and hHpr1-speciﬁc antibodies to assess the relative
amounts of each protein precipitated by ORF57 in the
absence or presence of PYMDNDC-FLAG. As shown in
Figure 6B, expression of PYMDNDC-FLAG resulted in a sig-
niﬁcant reduction in the amount of eIF4G bound to ORF57,
compared with cells co-expressing PYM-FLAG alone. In con-
trast, no decrease was observed in the amount of hHpr1
precipitated by ORF57 (Figure 6B), suggesting that
PYMDNDC-FLAG speciﬁcally ablates PYM-dependent ORF57
interactions. These data show that PYMDNDC-FLAG func-
tions as a dominant negative mutant that speciﬁcally disrupts
PYM-dependent ORF57 interactions.
We next sought to determine whether the ORF57-speciﬁc
loss of PYM function induced by PYMDNDC-FLAG resulted in
a decrease in the translation of KSHV intronless mRNAs. The
observation that hTREX proteins still interact with ORF57 in
the presence of PYMDNDC-FLAG (Figure 6B) suggests that
the mRNA nuclear export function of ORF57 is not effected by
co-expression of PYMDNDC-FLAG. To conﬁrm this, 293Tcells
were triple transfected with either pORF47GFP or pgB-HA, in
the absence or presence of ORF57 and either pPYM-FLAG or
pPYMDNDC-FLAG. At 24h post-transfection, cytoplasmic
RNA and total protein was isolated from each sample.
Cytoplasmic levels of ORF47 and gB-HA mRNA were deter-
mined by qRT–PCR to assess whether co-expression of
PYMDNDC-FLAG reduced the ability of ORF57 to export
mRNA. As reported earlier, we observed a dramatic increase
in the cytoplasmic levels of each intronless KSHV mRNA
reporter in the presence of ORF57 compared with control
(Nekorchuk et al, 2007). Figure 6C shows a comparative
enhancement of KSHV ORF47 and gB mRNA nuclear export
in cells expressing ORF57 in addition to either PYM-FLAG or
PYMDNDC-FLAG. We observed no signiﬁcant difference in
the fold increase of cytoplasmic mRNA levels of ORF47 or gB
(P¼0.43 and 0.39, respectively) present in cells expressing
ORF57 irrespective of whether these cells co-expressed PYM-
FLAG or PYMDNDC-FLAG (Figure 6C). These data, alongside
biochemical data in Figure 6B, suggest that PYMDNDC-FLAG
does not interfere with ORF57-mediated intronless KSHV
mRNA nuclear export.
To test whether expression of PYMDNDC-FLAG effected
the translational enhancement of intronless KSHV mRNA by
ORF57, western blot analysis was performed on the protein
samples isolated from the transfections described above.
To ensure that autoradiograph signals were not saturated,
which would limit densitometry analysis, a small amount of
total protein (15mg) was analysed (Figure 6D). As shown in
Figure 6E, both ORF47GFP and gB-HA were expressed at
signiﬁcantly higher levels in the presence of ORF57GFP
or ORF57mCherry, compared with GFP or mCherry alone
(14 and 11 fold, respectively). The co-expression of PYM-
FLAG had no signiﬁcant effect on the levels of each reporter
(P¼40.05 for gB and ORF47); however, co-expression of
PYMDNDC-FLAG resulted in a signiﬁcant decrease of both
gB-HA (decrease of 77.82%) and ORF47GFP (decrease of
55.84%), compared with FLAG control (P¼0.04 and 0.01,
respectively) (Figure 6E). Together, these data show that
PYMDNDC-FLAG has a speciﬁc dominant negative effect on
ORF57-mediated intronless mRNA translational enhance-
ment and that this effect is independent of ORF57-mediated
intronless KSHV mRNA export.
Moreover, to determine whether expression of PYMDNDC-
FLAG had any effect on virus replication, the KSHV-latently
infected 293T-BAC36 cell line was transfected with pFLAG,
pPYM-FLAG or pPYMDNDC-FLAG and concurrently reacti-
vated using TPA and incubated for 72h. The supernatants
from each ﬂask were then harvested and used to re-infect
293T cells. The level of virus replication was determined by
scoring the percentage of GFP positive cells 48h post-infec-
tion, as described earlier (Wilson et al, 2007). Similar levels
of lytic replication and virus production were observed from
pFLAG and pPYM-FLAG pre-transfected cells. Strikingly,
virus production from pPYMDNDC-FLAG pre-transfected
cells was reduced by approximately ﬁve-fold (Figure 6F).
These data show that wild-type PYM function is required
for normal levels of KSHV replication.
In summary, KSHV ORF57 appears to possess multi-func-
tionality with regards to viral mRNA processing. We show
that by interacting directly with PYM, ORF57 is able to link
intronless KSHV mRNAs to the 48S pre-initiation complex
and thereby enhance the translation of these viral mRNAs.
The function of PYM in this process is essential as perturba-
tion of PYM functionality ablates ORF57-mediated transla-
tional enhancement.
Discussion
The regulatory mechanisms responsible for the efﬁcient
translation of a newly exported mRNA are beginning to be
elucidated. In particular, the function of splicing, and speci-
ﬁcally the splicing-dependent deposition of the EJC, has
recently come to the fore. The nuclear–cytoplasmic shuttle
protein, PYM, was recently shown to link EJC-bound mRNAs
to the 48S pre-initiation complex during the so-called pioneer
round of translation (Ishigaki et al, 2001), thus increasing
translational efﬁciency (Diem et al, 2007). We have reported
earlier that KSHV ORF57 facilitates the export of intronless
KSHV mRNAs by recruiting the hTREX complex but fails to
recruit an EJC, prompting the question of how KSHV intron-
less mRNAs are efﬁciently translated. Here, we show for the
ﬁrst time that KSHV ORF57 interacts directly with PYM to
facilitate the efﬁcient translation of intronless KSHV tran-
scripts. The observation that ORF57 is able to enhance
translation of an intronless viral mRNA has parallels in
HSV-1, CMV and EBV, where ICP27, UL69 and SM, respec-
tively, have been shown to enhance the translation of viral
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Fontaine-Rodriguez and Knipe, 2008; Ricci et al, 2009; Aoyagi
et al, 2010). Moreover, these ﬁndings may have wider im-
plications for other viruses that require the export of intron-
less transcripts, such as inﬂuenza. The non-structural-1
(NS1) protein of inﬂuenza A has also been reported to
associate with components of the translation machinery, it
would be of interest, therefore, to assess whether PYM
associates with NS1 and inﬂuenza A intronless mRNA to
enhance their translation. It is also plausible that the PYM-
dependent increase of viral intronless mRNA translation
described herein, may mirror existing cellular pathways
that govern intronless mRNA translation. In support of this
hypothesis, cellular SR proteins that direct the nuclear export
of certain cellular intronless mRNA (e.g. Histone 2A), have
also been shown to enhance the recruitment of the transla-
tional machinery (Sanford et al, 2004). It is therefore tempt-
ing to suggest that cellular SR proteins, which are
functionally very similar to ORF57, may interact with and
use PYM to efﬁciently translate intronless mRNAs that are
unable to access EJC-dependent translational enhancement
machinery. The observation that PYM directly enhances the
translation of gM in the in vitro translation assay is, however,
not unexpected, as this assay identiﬁes general translational
enhancers, a category occupied by PYM due to its ability to
stabilize ribosomes (Diem et al, 2007).
Interestingly, KSHV ORF57 and homologues interact with
several translation factors (Fontaine-Rodriguez et al, 2004;
Aoyagi et al, 2010), suggesting that the assembly of such
factors onto viral mRNA may represent a common mechan-
ism used by herpesviruses. Importantly, the direct interaction
reported here between ORF57 and PYM, suggests a compel-
ling model for how ORF57 facilitates the assembly of the pre-
initiation complex on an intronless KSHV mRNA, whereby
ORF57 uses PYM as a linker protein to the 48S pre-initiation
complex. Such a model is reinforced by siRNA-mediated
depletion of PYM, which results in a signiﬁcant decrease in
the amount of ORF57 associated with translation factors. To
date, no other viral protein has been reported to interact with
PYM, and it will be of interest to determine whether ORF57
homologues also interact with PYM to link with cellular
translation machinery. During functional studies, we ob-
served that both the spliced ORF57 mRNA and a cellular,
spliced mRNA (b-actin) remained relatively unaffected by
siRNA-mediated PYM depletion. This was in direct contrast to
two intronless KSHV mRNAs (ORF54 and ORF59), both of
which exhibited a dramatic decrease in translation in PYM-
depleted cells. One possible explanation is that spliced
mRNAs have access to multiple mechanisms by which to
promote translation, whereas KSHV has evolved a single,
speciﬁc mechanism to enhance translation of intronless
transcripts. Recent work by Ma et al (2008) shows that
SKAR can recruit the mTOR-target kinase, S6K1, to newly
exported mRNA by acting as a linker protein between the EJC
and S6K1. Recruitment of S6K1 leads to an increase in
translation through the phosphorylation of pre-initiation
translation factors.
Given that the EJC appears to have multiple mechanisms
for increasing translation, it seems counter intuitive that
KSHV has not evolved to recruit a complete EJC to intronless
viral mRNA. One possible explanation is that in addition to
promoting translation, the EJC is also involved in negatively
regulating protein synthesis. Speciﬁcally, during translation,
a premature termination codon causes the ribosome to stall
and elicits the recruitment of a complex termed SURF.
Recruitment of SURF leads to a decrease in translation and
eventually degradation of the transcript (Isken et al, 2008).
Given the fact that an EJC is able to both positively and
negatively regulate translation, it is perhaps not surprising
that ORF57 fails to recruit an EJC, preferring instead to
associate with direct enhancers of translation, such as PYM.
Work is currently underway to determine whether ORF57
interacts with SKAR or SURF components. However, while
this manuscript was in preparation, it was reported that PYM
also functions to disassemble EJCs. PYM-dependent disas-
sembly of EJCs occurs immediately after nuclear export, and
it has been suggested that by coupling ribosome recruitment
to EJC disassembly, PYM ensures that newly exported
mRNAs are given preferential access to ribosomes. As
KSHV intronless mRNAs lack EJCs (Boyne et al, 2008b),
ORF57 may subvert PYM solely on the basis that it enables
efﬁcient access to ribosomes. Whether PYM remains bound
to ORF57 during steady-state translation, rather than being
recycled with EJC components following the pioneer round of
translation will be of interest to determine.
One important question is how and when ORF57 interacts
with PYM, an event that presumably then triggers the recruit-
ment of other translation factors to the intronless KSHV
mRNA. A clue may lie in the subcellular localization of
ORF57 and PYM. ORF57 exhibits a nuclear speckled and
nucleolar pattern of staining (Boyne and Whitehouse, 2009),
whereas PYM is localized exclusively in the cytoplasm (Diem
et al, 2007). Intriguingly, after treatment with the CRM1
inhibitor, leptomycin B, the localization pattern of PYM alters
and rather than being located in the cytoplasm, it is instead
retained in the nucleus and nucleolus. Interestingly, we
observed a clear colocalization of PYM and ORF57GFP in
the nucleolus of ORF57GFP-transfected cells and in KSHV-
reactivated cells, suggesting that ORF57 may redistribute a
proportion of PYM into the nucleolus or alternatively trafﬁck
through the nucleolus in a complex with PYM. We have
reported earlier that HVS ORF57 is able to redistribute
essential mRNA export proteins to the nucleolus (Boyne
and Whitehouse, 2006). These data raise the possibility that
the nucleolus is important for the export and subsequent
translation of viral RNPs. This is a hypothesis that is not
without precedence and represents an emerging theme in
messenger ribonucleoprotein particle (mRNP) biogenesis. For
example, the involvement of the nucleolus in mRNP biogen-
esis has been studied extensively in plants, where the nu-
cleolus has key functions in nonsense-mediated decay and
mRNA export (Brown and Shaw, 2008). More recently, work
on Saccharomyces cerevisiae has shown that nucleolar traf-
ﬁcking of the mRNA-transport protein, She2p, is essential for
the correct localization and translation of its target mRNA,
ASH1 (Du et al, 2008). Although the functional signiﬁcance of
KSHV ORF57 nucleolar localization remains unclear
(Nekorchuk et al, 2007; Boyne and Whitehouse, 2009),
nucleolar trafﬁcking of the HVS ORF57 protein is essential
for its function in viral mRNA nuclear export (Boyne and
Whitehouse, 2009). It will, therefore, be interesting to estab-
lish whether the observed redistribution of cellular mRNA
processing factors to the nucleolus is functionally important
with regards to KSHV replication.
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translational efﬁciency of intronless viral mRNA through a
direct interaction with PYM. Once recruited, PYM allows
ORF57-bound intronless KSHV mRNAs access to the pre-
initiation complex, an event that is essential for ORF57-
mediated enhancement of translation.
Materials and methods
Plasmid and antibody details
Details of oligonucleotides used in RT–PCR, cloning and site-directed
mutagenesis are presented in Supplementary Table S1. pORF57GFP
and pORF47 are described earlier (Boyne et al, 2008a). PYM constructs
and the PYM-speciﬁc mouse monoclonal antibody were gifts from
Gideon Dreyfuss (University of Pennsylvania). To generate GST-PYM
and GST-PYMDC, the PYM ORF was PCR ampliﬁed from pPYM-FLAG
and cloned into pGEX4T-1 (Pharmacia). To generate pPYMDNDC-
FLAG, a region of PYM lacking the ﬁrst 54 and last 53 amino acids was
PCR ampliﬁed from pPYM-FLAG, incorporating a single FLAG tag and
then cloned into pcDNA3.1. pORF57DRGG2 was generated using the
QuickChange II site-directed mutagenesis kit (Stratagene). Puriﬁed
bunyamwera virus nucleocapsid protein and puriﬁed His-tagged HIV
Nef protein was provided by John Barr and Mark Harris, respectively
(Leeds University). PABP-, eIF4A-, eIF4G- and eIF4E-speciﬁc anti-
bodies were gifts from Simon Morley (University of Sussex) and Ian
Goodfellow (Imperial College, London). ORF54-speciﬁc antibodies
were provided by Friedrich Gra ¨sser (Universita ¨tskliniken, Germany).
ORF57-speciﬁc antibody was described earlier (Boyne et al, 2008a).
ORF59- (Autogen Bioclear), p53- (Pharmagen Inc), GFP- (BD
Biosciences) FLAG-, b-actin-, SC-35- (Sigma) antibodies were pur-
chased from their respective suppliers. Unless stated otherwise, all
antibodies were used at a dilution of 1:1000 for western blot analysis.
Cell culture, viruses and transfection
HEK-293T and 293T-BAC36 cells were cultured in Dulbecco’s
modiﬁed Eagle medium (DMEM, Invitrogen, Paisley, UK), KSHV-
infected BCBL-1 cells were cultured in RPMI medium (Invitrogen,
Paisley, UK) both media were supplemented with 10% foetal calf
serum (FCS, Invitrogen), glutamine and penicillin-streptomycin. Sf9
cells were cultured in Sf-900 II SFM (Invitrogen, Paisley, UK). BCBL-
1 cells were reactivated using TPA (20ng/ml) for the designated
time. Plasmid transfections were carried out using Lipofectamine
2000 (Invitrogen, Paisley, UK), as per the manufacturer’s instruc-
tions. KSHV replication assays were performed as described earlier
(Wilson et al, 2007).
Expression and puriﬁcation of recombinant proteins
Recombinant GST-ORF57, GST-PYM and GST-PYMDC were ex-
pressed and puriﬁed as described earlier (Malik et al, 2004). Further
puriﬁcation was performed using a Superdex 200 10/300 GL
Column (GE Healthcare). The nucleocapsid bunyamwera virus
protein was expressed and puriﬁed as described earlier (Rodgers
et al, 2006). Baculovirus recombinant ORF57-6xHis was produced,
expressed and puriﬁed as described by the manufacturer (Invitro-
gen) using the pFASTBac protocol.
In vitro transcription and translation
In vitro translation reactions were performed using the Flexi rabbit
reticulocyte lysate system (Promega Inc) or human in vitro protein
expression kit (Pierce) using 25mg/ml of in vitro transcribed RNA.
The in vitro transcription of gM or luciferase was performed using
the MAXIscript kit (Ambion Inc). The concentration of RNA used
was chosen to give a linear yield of translated product over the time
course of translation (90min). In reactions that required the
addition of heterologous protein (0.5, 1 or 2.5mg), or (0, 1, or
2.5mg), the reactions were pre-incubated at 301C for 15min before
the addition of RNA. After 90min, the reactions were terminated by
the addition of SDS–PAGE sample buffer, resolved on 9%
polyacylamide gels and subsequently the dried gel was exposed
to autoradiograph ﬁlm for 16h.
Sucrose gradients
Sucrose gradient fractionation was essentially carried out as
described elsewhere (Diem et al, 2007). Brieﬂy, BCBL-1 cells were
reactivated using TPA (20ng/ml) for 16h, before 2h treatment with
cyclohexamide (100mg/ml). Cytoplasmic extracts were isolated and
loaded onto a 5–20% linear sucrose gradient then centrifugated at
28800r.p.m. in a Beckman SW41.1 rotor for 3h at 41C. Fractions
were collected from the top of the gradient using a Biocomp
fractionator (Biocomp, NB Canada) and total protein or RNA was
extracted from 100ml of each fraction by boiling with 2  protein
loading solution or extraction with Trizol (Invitrogen), respectively.
Immunoprecipitation assays and RNA analysis
GST pull downs and Co-IPs were performed as described earlier
(Hall et al, 2002; Gould et al, 2009). RNA –immunoprecipitations
were performed as described earlier (Boyne and Whitehouse, 2006).
Quantitative RT–PCR was performed as described earlier (Boyne
and Whitehouse, 2009).
Immunoﬂuorescence
Immunoﬂuorescence staining was carried out as described earlier
(Boyne and Whitehouse, 2006). Immunoﬂuorescence was visua-
lized on an LSM 510 Meta confocal microscope (Zeiss) and images
analysed using the manufacturer’s software.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
Acknowledgements
We are indebted to Gideon Dreyfuss (Howard Hughes Medical School,
Pennsylvania, PA), Robin Reed (Harvard University, Boston, MA), Ian
Goodfellow (Imperial College, London), Simon Morley (University of
Sussex), John Barr, Mark Harris (University of Leeds) and Gary
Hayward (Johns Hopkins, Baltimore, MD) for providing reagents
and to Simon White (University of Leeds) for his technical assistance.
This work was supported in part by Wellcome Trust (086168/Z08/Z)
and BBSRC (BB/F012101/1) project grants. AW is the recipient of a
BBSRC Research Development Fellowship.
Conﬂict of interest
The authors declare that they have no conﬂict of interest.
References
Aoyagi M, Gaspar M, Shenk TE (2010) Human cytomegalovirus
UL69 protein facilitates translation by associating with the mRNA
cap-binding complex and excluding 4EBP1. Proc Natl Acad Sci
USA 107: 2640–2645
Bono F, Ebert J, Unterholzner L, Guttler T, Izaurralde E, Conti E (2004)
Molecular insights into the interaction of PYM with the Mago-Y14
core of the exon junction complex. EMBO Rep 5: 304–310
Boyne JR, Colgan KJ, Whitehouse A (2008a) Herpesvirus saimiri
ORF57: a post-transcriptional regulatory protein. Front Biosci 13:
2928–2938
Boyne JR, Colgan KJ, Whitehouse A (2008b) Recruitment of the
complete hTREX complex is required for Kaposi’s sarcoma-asso-
ciated herpesvirus intronless mRNA nuclear export and virus
replication. PLoS Pathog 4: e1000194
Boyne JR, Whitehouse A (2006) Nucleolar trafﬁcking is essential for
nuclear export of intronless herpesvirus mRNA. Proc Natl Acad
Sci USA 103: 15190–15195
Boyne JR, Whitehouse A (2009) Nucleolar disruption impairs
Kaposi’s sarcoma-associated herpesvirus ORF57-mediated nucle-
ar export of intronless viral mRNAs. FEBS Lett 583: 3549–3556
Braddock M, Muckenthaler M, White MR, Thorburn AM, Sommerville
J, Kingsman AJ, Kingsman SM (1994) Intron-less RNA injected into
the nucleus of Xenopus oocytes accesses a regulated translation
control pathway. Nucleic Acids Res 22: 5255–5264
Interaction of KSHV ORF57 with PYM and viral intronless mRNAs
JR Boyne et al
&2010 European Molecular Biology Organization The EMBO Journal VOL 29 | NO 11 | 2010 1863Brown JW, Shaw PJ (2008) The role of the plant nucleolus in pre-
mRNA processing. Curr Top Microbiol Immunol 326: 291–311
Callis J, Fromm M, Walbot V (1987) Introns increase gene expres-
sion in cultured maize cells. Genes Dev 1: 1183–1200
Chang Y, Moore PS (1996) Kaposi’s sarcoma (KS)-associated her-
pesvirus and its role in KS. Infect Agents Dis 5: 215–222
Chang YF, Imam JS, Wilkinson MF (2007) The nonsense-mediated
decay RNA surveillance pathway. Annu Rev Biochem 76: 51–74
Chen IH, Li L, Silva L, Sandri-Goldin RM (2005) ICP27 recruits Aly/
REF but not TAP/NXF1 to herpes simplex virus type 1 transcrip-
tion sites although TAP/NXF1 is required for ICP27 export. J Virol
79: 3949–3961
Cheng H, Dufu K, Lee CS, Hsu JL, Dias A, Reed R (2006) Human
mRNA export machinery recruited to the 50 end of mRNA. Cell
127: 1389–1400
Colgan K, Boyne JR, Whitehouse A (2009) Uncoupling of hTREX
demonstrates that UAP56 and hTHO-complex recruitment onto
herpesvirus saimiri intronless transcripts is required for replica-
tion. J Gen Virol 90 (Part 6): 1455–1460
Diem MD, Chan CC, Younis I, Dreyfuss G (2007) PYM binds the
cytoplasmic exon-junction complex and ribosomes to enhance
translation of spliced mRNAs. Nat Struct Mol Biol 14: 1173–1179
Du TG, Jellbauer S, Muller M, Schmid M, Niessing D, Jansen RP
(2008) Nuclear transit of the RNA-binding protein She2 is re-
quired for translational control of localized ASH1 mRNA. EMBO
Rep 9: 781–787
Fontaine-Rodriguez EC, Knipe DM (2008) Herpes simplex virus
ICP27 increases translation of a subset of viral late mRNAs.
J Virol 82: 3538–3545
Fontaine-Rodriguez EC, Taylor TJ, Olesky M, Knipe DM (2004)
Proteomics of herpes simplex virus infected cell protein 27: associa-
tion with translation initiation factors. Virology 330: 487–492
Gao SJ, Deng JH, Zhou FC (2003) Productive lytic replication of a
recombinant Kaposi’s sarcoma-associated herpesvirus in efﬁcient
primary infection of primary human endothelial cells. J Virol 77:
9738–9749
Goodwin DJ, Whitehouse A (2001) A gamma-2 herpesvirus nucleo-
cytoplasmic shuttle protein interacts with importin alpha 1 and
alpha 5. J Biol Chem 276: 19905–19912
Gould F, Harrison SM, Hewitt EW, Whitehouse A (2009) Kaposi’s
sarcoma-associated herpesvirus RTA promotes degradation of
the Hey1 repressor protein through the ubiquitin proteasome
pathway. J Virol 83: 6727–6738
Grifﬁths R, Whitehouse A (2007) Herpesvirus saimiri episomal
persistence is maintained via interaction between open reading
frame 73 and the cellular chromosome-associated protein MeCP2.
J Virol 81: 4021–4032
Gudikote JP, Imam JS, Garcia RF, Wilkinson MF (2005) RNA
splicing promotes translation and RNA surveillance. Nat Struct
Mol Biol 12: 801–809
Hall KT, Giles MS, Calderwood MA, Goodwin DJ, Matthews DA,
Whitehouse A (2002) The herpesvirus saimiri open reading frame
73 gene product interacts with the cellular protein p32. J Virol 76:
11612–11622
Harris M, Coates K (1993) Identiﬁcation of cellular proteins that bind
to the human immunodeﬁciency virus type 1 nef gene product
in vitro: a role for myristylation. JG e nV i r o l74 (Part 8): 1581–1589
Hautbergue GM, Hung ML, Walsh MJ, Snijders AP, Chang CT, Jones
R, Ponting CP, Dickman MJ, Wilson SA (2009) UIF, a new mRNA
export adaptor that works together with REF/ALY, requires FACT
for recruitment to mRNA. Curr Biol 19: 1918–1924
Ishigaki Y, Li X, Serin G, Maquat LE (2001) Evidence for a pioneer
round of mRNA translation: mRNAs subject to nonsense-
mediated decay in mammalian cells are bound by CBP80 and
CBP20. Cell 106: 607–617
Isken O, Kim YK, Hosoda N, Mayeur GL, Hershey JW, Maquat LE
(2008) Upf1 phosphorylation triggers translational repression
during nonsense-mediated mRNA decay. Cell 133: 314–327
Jurica MS, Moore MJ (2003) Pre-mRNA splicing: awash in a sea of
proteins. Mol Cell 12: 5–14
Koffa MD, Clements JB, Izaurralde E, Wadd S, Wilson SA, Mattaj
IW, Kuersten S (2001) Herpes simplex virus ICP27 protein pro-
vides viral mRNAs with access to the cellular mRNA export
pathway. EMBO J 20: 5769–5778
Kohler A, Hurt E (2007) Exporting RNA from the nucleus to the
cytoplasm. Nat Rev Mol Cell Biol 8: 761–773
Larralde O, Smith RW, Wilkie GS, Malik P, Gray NK, Clements JB
(2006) Direct stimulation of translation by the multifunctional
herpesvirus ICP27 protein. J Virol 80: 1588–1591
Le Hir H, Izaurralde E, Maquat LE, Moore MJ (2000) The spliceo-
some deposits multiple proteins 20–24 nucleotides upstream of
mRNA exon-exon junctions. EMBO J 19: 6860–6869
Lu S, Cullen BR (2003) Analysis of the stimulatory effect of splicing
on mRNA production and utilization in mammalian cells. RNA 9:
618–630
Ma XM, Yoon SO, Richardson CJ, Julich K, Blenis J (2008) SKAR
links pre-mRNA splicing to mTOR/S6K1-mediated enhanced
translation efﬁciency of spliced mRNAs. Cell 133: 303–313
Majerciak V, Kruhlak M, Dagur PK, McCoy Jr JP, Zheng ZM (2010)
Caspase-7 cleavage of Kaposi sarcoma-associated herpesvirus
ORF57 confers a cellular function against viral lytic gene expres-
sion. J Biol Chem 285: 11297–11307
Majerciak V, Yamanegi K, Nie SH, Zheng ZM (2006) Structural and
functional analyses of Kaposi sarcoma-associated herpesvirus
ORF57 nuclear localization signals in living cells. J Biol Chem
281: 28365–28378
Malik P, Blackbourn DJ, Clements JB (2004) The evolutionarily
conserved Kaposi’s sarcoma-associated herpesvirus ORF57 pro-
tein interacts with REF protein and acts as an RNA export factor. J
Biol Chem 279: 33001–33011
Matsumoto K, Wassarman KM, Wolffe AP (1998) Nuclear history of
a pre-mRNA determines the translational activity of cytoplasmic
mRNA. EMBO J 17: 2107–2121
Nekorchuk M, Han Z, Hsieh TT, Swaminathan S (2007) Kaposi’s
sarcoma-associated herpesvirus ORF57 protein enhances mRNA
accumulation independently of effects on nuclear RNA export. J
Virol 81: 9990–9998
Nott A, Le Hir H, Moore MJ (2004) Splicing enhances translation in
mammalian cells: an additional function of the exon junction
complex. Genes Dev 18: 210–222
Peterson TR, Sabatini DM (2005) eIF3: a connecTOR of S6K1 to the
translation preinitiation complex. Mol Cell 20: 655–657
Reed R, Cheng H (2005) TREX, SR proteins and export of mRNA.
Curr Opin Cell Biol 17: 269–273
Ricci EP, Mure F, Gruffat H, Decimo D, Medina-Palazon C, Ohlmann
T, Manet E (2009) Translation of intronless RNAs is strongly
stimulated by the Epstein-Barr virus mRNA export factor EB2.
Nucleic Acids Res 37: 4932–4943
Rodgers JW, Zhou Q, Green TJ, Barr JN, Luo M (2006) Puriﬁcation,
crystallization and preliminary X-ray crystallographic analysis of
the nucleocapsid protein of Bunyamwera virus. Acta Crystallogr
Sect F Struct Biol Cryst Commun 62: 361–364
Ruvolo V, Gupta AK, Swaminathan S (2001) Epstein-Barr virus SM
protein interacts with mRNA in vivo and mediates a gene-speciﬁc
increase in cytoplasmic mRNA. J Virol 75: 6033–6041
Sanford JR, Gray NK, Beckmann K, Caceres JF (2004) A novel role
for shuttling SR proteins in mRNA translation. Genes Dev 18:
755–768
Sergeant A, Gruffat H, Manet E (2008) The Epstein-Barr virus (EBV)
protein EB is an mRNA export factor essential for virus produc-
tion. Front Biosci 13: 3798–3813
Swaminathan S (2005) Post-transcriptional gene regulation by
gamma herpesviruses. J Cell Biochem 95: 698–711
Williams BJ, Boyne JR, Goodwin DJ, Roaden L, Hautbergue GM,
Wilson SA, Whitehouse A (2005) The prototype gamma-2 her-
pesvirus nucleocytoplasmic shuttling protein, ORF 57, transports
viral RNA through the cellular mRNA export pathway. Biochem J
387: 295–308
W i l s o nS J ,T s a oE H ,W e b bB L ,Y eH ,D a l t o n - G r i f ﬁ nL ,T s a n t o u l a sC ,
Gale CV, Du MQ, Whitehouse A, Kellam P (2007) X box binding
protein XBP-1s transactivates the Kaposi’s sarcoma-associated her-
pesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation
to KSHV reactivation from latency. JV i r o l81: 13578–13586
The EMBO Journal is published by Nature
Publishing Group on behalf of European
Molecular Biology Organization. This article is licensed
under a Creative Commons Attribution-Noncommercial-
NoDerivativeWorks3.0Licence.[http://creativecommons.
org/licenses/by-nc-nd/3.0]
Interaction of KSHV ORF57 with PYM and viral intronless mRNAs
JR Boyne et al
The EMBO Journal VOL 29 | NO 11 | 2010 &2010 European Molecular Biology Organization 1864